
Lab testing per US FDA requirements for consumer injectables • Accuracy Matters. Results You Can Trust. • FDA #3034276914 • Women-Owned Small Business
Dorr, MI
Joined November 2024
- Tweets585
- Following91
- Followers1.1K
- Likes289
TrustPointe Analytics 🥼 retweeted
🚨How some peptide labs actually work.
- 99.9% purity is a $10 add-on.
- The fentanyl screen comes back “not detected” by default.
- Express service gets you results before the sample even arrives, and for $9 a brand, the same COA goes on 11 other websites.
Ask your vendor who tested it, and whether the lab ever saw the vial.
Labs we recommend : @TrustPointe , @finnrick_tests , Janoshik.
TrustPointe Analytics 🥼 retweeted
Replying to @5StarLabs @Vanguard_Lab
Apologies for the novel, but this is one that irritates me. A negative PCR ≠ a USP 71(or 73) passing sterility.
There's a significant difference between detecting microbial DNA and demonstrating the absence of viable microbial contamination using a validated sterility procedure.
USP <71> testing relies on microbial growth in 2 types of media over 14 days. PCR detects nucleic acid sequences. Depending on the assay, that DNA may originate from viable organisms, dead organisms, or residual microbial material. A negative PCR result also does not establish that viable contamination is absent, particularly when the organism concentration is below the PCR detection limit.
It's more than a theoretical concern, or semantics. Broad-range 16S PCR for sterility screening reported detection sensitivities ranging from 10 to 100 CFU/mL. Thats substantial when evaluating products where contamination may consist of only a few viable organisms.
Another important distinction is that 16S PCR primarily detects bacteria. It does not adequately address fungal contamination. Adding a fungal PCR assay improves coverage, but it does not automatically establish equivalence to USP <71>. Much of the failed USP 71 sterility tests of RUO
I also reviewed and frequently used commercial PCR systems. Sartorius, one of the major manufacturers in this field, has published studies demonstrating favorable comparisons between its Microsart PCR assays and traditional compendial methods.
However, Sartorius explicitly states in its own technical documentation that its Microsart ATMP system is not a replacement for classical USP <71> sterility testing.
It's good for a screen for products manufactured in highly controlled and regulated cGMP environments. I often used it to quickly screen raw materials and finished productstopical formulations. I would never rely on it for products where nothing concerning the manufacturing can be confirmed, or where the product would be injected.
There is a difference between demonstrating comparable analytical performance in a limited study and validating a method as a replacement for compendial sterility testing across different pharmaceutical formulations.
A 2019 study published in the Journal of Clinical Microbiology evaluated 118 microbial isolates using traditional USP <71> and alternative automated culture systems. One alternative system detected only 71.2% of the organisms after extended incubation.
Validated USP 71 methods do exist.
At @Vanguard_Lab , we offer traditional USP <71> sterility testing as well as rapid sterility testing using the Charles River Celsis ATP bioluminescence system, validated as an alternative to USP <71>. To put in perspective, we paid over 100K for the instrument and nearly another 100k on validation and method suitability studies of more than 50 different peptides at different mgs, different filler materials, and different combinations of peptides.
Celsis uses microbial growth followed by ATP-based detection, allowing a shortened incubation period while retaining a growth-based approach to detecting viable contamination.
We also participate in independent, third-party Pharma ISO accredited proficiency testing with our traditional USP <71> and USP <71>-equivalent rapid sterility methods That provides an additional external assessment of laboratory performance beyond our internal quality controls and method validation.
USP also specifically addresses certain rapid sterility technologies under chapters <72> and <73>, including respiration-based detection and ATP bioluminescence for applicable short-life products.
PCR is not inherently excluded from alternative-method validation. USP <1223> provides a framework for evaluating alternative microbiological technologies. However, I have not found evidence that a commercially available standalone PCR kit is universally recognized by USP as a direct replacement for USP <71>, Nor have I seen any evidence that anyone in this space using PCR is doing method suitability on PC methods or participating in proficiency testing.
If a laboratory is advertising PCR screen as a USP <71> sterility test, I would ask to see the validation demonstrating that equivalence, including low-level microbial recovery, bacterial and fungal coverage, product-specific suitability, assay inhibition, and detection probability at very low contamination levels.
I would also want to know whether that laboratory participates in independent proficiency testing for the methodology being offered.
We use molecular methods at Vanguard, and consider PCR an extremely valuable tool for pathogen detection and identification. We use it daily in our food and pharma departments. It can also be useful for rapid preliminary screening but screening and compendial sterility testing are not interchangeable.
There is nothing wrong with offering PCR microbial screening. There is a problem with advertising that screening as USP <71> sterility testing without the necessary supporting validation. If someone wants us to provide a rapid PCR or other rapid micro method we are happy to do so, but we will not list it on our COA as USP 71, or sterility.
The distinction matters scientifically, analytically, and from a regulatory standpoint.
TrustPointe Analytics 🥼 retweeted
Replying to @JoshInProgress @Krysia830073
TM-1025 Eloralintide Method Validation Results
USP <1225>: Pass
Range: 20-300ppm
Linearity r2: 1.000
20ppm Recovery: 99.9% RSD 1.7%
50ppm Recovery: 100.3% RSD 1.5%
100ppm Recovery: 101.0% RSD 0.4%
150ppm Recovery: 99.7% RSD 0.4%
200ppm Recovery: 99.7% RSD 0.1%
300ppm Recovery: 99.6% RSD 0.2%
TrustPointe Analytics 🥼 retweeted
Replying to @mannyjplays
We have 100mg GHK-Cu in 6ml vials on their way to @TrustPointe right now. Big testing panel. You’ll be able to save yourself the hassle of moving into that second vial
TrustPointe Analytics 🥼 retweeted
Many thanks to @RegenRandy for taking the @TrustPointe ordering process for a spin and giving us some actionable feedback!
TrustPointe Analytics 🥼 retweeted
Replying to @TrustPointe
You set up an audit group? You utter madman, I love it.
TrustPointe Analytics 🥼 retweeted
Replying to @TrustPointe
This is exactly where the industry needs to go. Tested batch linked to the actual vial in your hand. No more taking a vendor's word for it.
TrustPointe Analytics 🥼 retweeted
Replying to @TrustPointe @huge_flood
Res Labs + Trust Pointe is goated. The best of both worlds
TrustPointe Analytics 🥼 retweeted
this is gonna ruffle some feathers but… subpar labs for testing peptides:
Freedom
ILS
BT Labs
Krause
great labs:
Chromate
Uzorak
Janoshik
TrustPointe
MZ Biolabs
TrustPointe Analytics 🥼 retweeted
Hot take:
People seeing the cost per vial from China are “outraged” by reseller pricing.
What they don’t see:
Spending all hours of the night on Whatsapp trying to find a legitimate supplier.
Hours of negotiation to arrive at pricing and a proforma invoice.
Taking a risk and wiring $20k overseas, knowing you may never see product.
If they ship it, there’s a 10% chance CBP deletes it at the border, and you have no recourse with the supplier.
If you do get it, you have to find a lab that tests it - and some are 2-3 weeks out. There’s a 20-30% chance it’s garbage. You are out the test money and the supplier will argue the results (or ghost you).
Then you sell it, and your processor fines you $50k for selling them. And people scam you by saying they never got the order.
It’s easy to see two numbers and not see all of the risk and losses between the two.
Prices will come down due to competition, but people are entitled to earn money for the risk and effort they put in.
TrustPointe Analytics 🥼 retweeted
We are very conservative on purity.
Unless we know what an atypical peak is, it is integrated and included in the purity value, causing it to be lower.
We have worked with willing manufacturers to inject multiple excipients on our methods to see if they align with the atypical peak - at which point we would be comfortable labeling that peak as an excipient and not including it in the purity calculation.
TrustPointe Analytics 🥼 retweeted
Replying to @RegenRandy @BrentPSorensen
I understand.
It’s tough because lab methods are IP, and the way a lab does something may be more efficient / better than other labs, and they risk giving up their sauce in a video. Ashlee won’t let me do one for that reason (she’s wiser than me).
This is handled in industry by requiring method validation data. If your lab has data demonstrating Accuracy, Precision, Linearity, Range, Specificity, etc according to a recognized standard like USP 1225, the proprietary method details on how they got there aren’t necessary.
Any lab attacking another lab better have method validation receipts.
Also remember that samples are rarely run in isolation, so if the rest of the samples on the HPLC run were fine, yours is probably just bad. We share the run data for every run, so systemic errors like a bad reference standard would be highly visible.
Re: 10mg vs 15mg errors
10 and it should have been 15
> sample mix up
> lost material during quantitative transfer
> incorrect sample dilution - overdilution
> sample not fully dissolved
> calculation error
> data entry error
> issue with reference standard (but it would bias all results on the run down)
> HPLC system/detector issue (system suitability checks should catch. Would affect other samples on the run)
> bad peak integration (cut off part of the peak, although it would have to be really bad here)
If they got 15 and it should have been 10
> sample mix up
> incorrect sample dilution - underdilution
> calculation error
> data entry error
> issue with reference standard (but it would bias all results up
> HPLC system/detector issue (system suitability checks should catch. Would affect other samples on the run)
> coelution due to poor separation (inflates peptide peak area)
> bad peak integration (integrated a huge front/tail and or other peaks including the peptide peak, although it would have to be really bad here)
Replying to @TrustPointe
I’ve used you guys a few times and was always happy with the service… I think accurate testing, fair pricing, quick turnaround times, and great customer service are key..
I got this from TrustPointe..
TrustPointe Analytics 🥼 retweeted
Well, USP <905> Content Uniformity on my RT10s from China FAILED
A 🧵
TrustPointe Analytics 🥼 retweeted
We left dry retatrutide in a truck and on a sunny windowsill all summer. The fridge group got the VIP treatment.
Then @TrustPointe tested the samples.
High purity. Lower measured content outside the fridge. Randy brought receipts. 🐀👇
peptidecritic.com/lab-report…
you’re paying for testing on the good ones too.
And you’re paying for the allocation of risk off yourself. You can legally buy research chems for yourself and not get in trouble at all. There is no fine for buying bpc 157 for research purposes for YOURSELF.
The RUO brands assume the risk for buying the chems and selling them under a thin guise and pass off the cost to the consumer for doing so.
The other alternative is to find a good Chinese plug and cut out the middle man but the downsides are very little of them do 3rd party testing and many have MOQs or “kits”
The allocation of risk and testing demands a premium that RUO vendors can pass off to consumers.
Simple economics really.
TrustPointe Analytics 🥼 retweeted
Replying to @RegenRandy @PharmerBobby
I guess my point is that the less expensive labs are going to get more expensive
Also there is an opportunity cost you are missing by not being able to sell product as your wait on testing
TrustPointe Analytics 🥼 retweeted
Replying to @JoshInProgress @TrustPointe
3-5 day turnaround is solid
TrustPointe Analytics 🥼 retweeted
Replying to @blankpeptides
heads up - while investigating another shop we found your freedom diagnostics COAs being reused with the client name changed to theirs and their product photo swapped in. the lab's search code still starts with "Blan" which is how it was caught. full writeup: peptigrity.com/discussions/h…
















